Navigation Links
Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin America
Date:2/26/2008

Six Million Doses of Stamaril(TM) Vaccine Shipped in Record Time to Brazil

and Paraguay

LYON, France, February 26 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of the Sanofi-aventis Group, announced today that six million doses of Stamaril(TM)(1) yellow fever vaccine have been shipped upon UNICEF's request to respond to the yellow fever epidemic in Latin America.

Brazil received four million doses of Stamaril(TM) vaccine early February and an additional two million doses were shipped to Paraguay over the weekend in response to urgent requests from Health Authorities.

"Sanofi Pasteur mobilized its teams to make this public health emergency a priority," said Wayne Pisano, President and Chief Executive Officer of Sanofi Pasteur. "This ability to respond to an emergency in record time illustrates the company's commitment to global health."

The yellow fever vaccine that was provided to Brazil and Paraguay is part of the UNICEF vaccine stockpile which is reserved for outbreak responses. Sanofi Pasteur is currently the only vaccine supplier to the UNICEF yellow fever vaccine stockpile.

Sanofi Pasteur is the largest provider of yellow fever vaccine worldwide with 200 million doses of vaccine provided to 150 countries over the past 20 years.

About yellow fever

Yellow fever is a viral disease that occurs in both rural and urban areas in Africa and South America. There is no treatment for yellow fever, only prevention by immunization. More than 200,000 people contract the disease and 30,000 people die from it each year. According to the WHO, over 30 countries in Africa (with an estimated population of 508 million) are at risk. In the Americas, yellow fever is endemic in nine South American countries and in several Caribbean islands.

About Sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic sol
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
3. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
4. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis
6. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
7. Pasteuria Bioscience Taps New CEO David N. Duncan
8. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
9. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
10. Triage study challenges notions of emergency medical response to disaster
11. National Association of Emergency Medical Technicians (NAEMT) Supports Prehospital Screening for Carbon Monoxide in the Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (NASDAQ: ONCE ) announced today that members ... and Company Health Care Conference on Wednesday, March 4, ... Copley Place. To access the live webcast ... please visit the "Upcoming Events" section within the "News ... www.sparktx.com .  A replay of the webcast will ...
(Date:2/26/2015)... Feb. 26, 2015 Caris Life Sciences® ... the 2015 Genitourinary Cancers Symposium in ... utility of tumor profiling. Both studies utilized Caris ... service, to identify biomarkers that shed light on ... small cell bladder cancer (SCBC). ...
(Date:2/25/2015)... Calif. , Feb. 25, 2015 ... nootropic drink, is featured in this week,s Power ... cnbc.com/id/102454724 , to discuss the company,s traction and ... offering through the crowd funding site CircleUp. ... novel products that are validated by neurotechnology, while ...
(Date:2/25/2015)... 2015 Market Publishers Ltd is happy ... by 9Dimen Research have been recently uploaded to its ... Market Research Report . This research report provides wealth ... the world adhesive mortar industry as well as includes ... major regional markets. It focuses on the main regions ...
Breaking Biology Technology:Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 4
... , ... , , , ... samples of low cell numbers , , , ... cells have, for example,limited availability, quantity,and lifespan. Using the Agilent,2100 bioanalyzer ...
... , , , ... , , , , ... Agilent 2100 bioanalyzer can,be used to analyze apoptotic cell samples. Performance ... compared to,those obtained with a conventional flow cytometer. Histogram quality,of the ...
... , , , , ... The In Situ Cell Death Detection Kit has been designed as a precise, fast, and simple, ... the single-cell level in tissues. It is based on the so-called TUNEL, ... , , , , ...
Cached Biology Technology:Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 2Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 3Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 2Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 3Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 4Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 5Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 6Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 7Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 8Apoptosis detection by annexin V and,active caspase-3 with the Agilent 2100,bioanalyzer 9In Situ Cell Death Detection Kit 2
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( ... launched its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz ... build of production capacity to meet customer demand. ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... the Exploitation of Meteorological Satellites, agreed today that ... the last two Meteosat Second Generation (MSG) satellites, ... will provide control services during the critical launch ... the satellite from its initial position after separation ...
... 6 Foregoing food for a day each month ... the Church of Jesus Christ of Latter-Day Saints (LDS ... than other Americans, researchers reported at the American Heart ... receive a heart-protective benefit, and this appeared to also ...
... if the babies have a genetic variant that enhances their ... today in Proceedings of the National Academy of Sciences. ... in the control of fatty acid pathways, that may help ... promote the brain development that is associated with a higher ...
Cached Biology News:ESA to provide essential launch control services to EUMETSAT 2ESA to provide essential launch control services to EUMETSAT 3People who skip meals: are they better off? 2People who skip meals: are they better off? 3Breastfeeding boost IQ in infants with 'helpful' genetic variant 2